Browsing by Author Sievert, William

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2014Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studiesBooth, David; George, Jacob; McCaughan, Geoffrey William; Bollipo, Steven; Cheng, Wendy; Crawford, Darrell; Dore, Gregory; Leung, Reynold; Mitchell, Joanne; Ostapowicz, George; Roberts, Stuart; Sievert, William; Sloss, Andrew; Thompson, Alexander; Weltman, Martin; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Centenary InstituteDistribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies, Journal of Gastroenterology and Hepatology, vol.29, 1, 2014,pp 179-184
2011Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patientsWeltman, Martin; Baleriola, Cristina; Chaverot, S; Cheng, Wendy; Crawford, Darrell; Dore, Greg; Dubois, Dwight; McCaughan, Geoffrey W.; Rawlinson, William D.; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Stelzer-Braid, Sacha; Thommes, James; Yoshihara, Motoko; Nepean Clinical School: MedicineEffect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients, Antiviral Therapy, vol.16, 2, 2011,pp 173-180
2002Factors associated with severity of Hepatic Fibrosis in People With Chronic Hepatitis C InfectionDanta, Mark; Farrell, Geoffrey; Ngu, Meng; Batey, Robert G; Desmond, Paul V; Dore, Gregory J.; Harley, Hugh; Hennessy, Lisa; Kaldor, John M.; Li, Yueming; Reed, William; Sievert, William; Vickers, Chris R; Medicine; Western Clinical School: Westmead Millennium Institute; Concord Clinical School: MedicineFactors associated with severity of Hepatic Fibrosis in People With Chronic Hepatitis C Infection, Medical Journal of Australia, vol.177,(N/A),2002,pp 240-245
2017Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapyGeorge, Jacob; Strasser, Simone; Desmond, Paul; et al, Various; Lee, Alice; Lim, Lucy; Nicoll, Amanda J.; Patterson, Scott; Roberts, Stuart; Sievert, William; Thompson, Alexander; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: MedicineFive-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy, Liver International, vol.37, 6, 2017,pp 827-835
2009Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.McCaughan, Geoffrey; Weltman, Martin; Cheng, Wendy; Crawford, Darrell; DePamphilis, Jean; Desmond, Paul V; Dore, Gregory J.; Marks, Phillipa; Rawlinson, William D.; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Yoshihara, Motoko; Central Clinical School: Centenary Institute; Nepean Clinical School: MedicineImpact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial., Hepatology, vol.50, 4,pp 1045-1055
2014Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infectionGeorge, Jacob; Leung, Reynold; Button, Peter; Cheng, Wendy; Crawford, Darrell H G; Dore, Gregory J.; Kitson, Matthew; McCaughan, Geoffrey W.; Roberts, Stuart; Sievert, William; Weltman, Martin; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead)Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection, Journal of Gastroenterology and Hepatology, vol.29, N/A, 2014,pp 1458-1462
2010Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosingWeltman, Martin; Cheng, Wendy; Crawford, Darrell; Dore, Gregory J.; Marks, Phillipa; McCaughan, Geoffrey W.; Rawlinson, William; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Thommes, James; Yoshihara, Motoko; Nepean Clinical School: MedicineLow virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing, Journal of Hepatology, vol.53, 4,pp 616-623
2011A systematic review of hepatitis C virus epidemiology in Asia, Australia and EgyptMcCaughan, Geoffrey; Abdo, Ayman; Ahmed, Ezzat Ali; AlOmair, Ahmed; Altraif, Ibrahim; Amarapurkar, D.; Chen, Chien-Hung; Dou, Xiaoguang; El Khayat, Hisham; et al, various; Razavi, Homie; Sievert, William; Central Clinical School: Centenary InstituteA systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt, Liver international, vol.31, Suppl 2, 2011,pp 61-80
2010Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis BGeorge, Jacob; Strasser, Simone; Angus, P.; Bowden, S; Desmond, Paul V; Lee, Alice U; Locarnini, S; Nicoll, A; Patterson, S; Roberts, Stuart; Sievert, William; Western Clinical School: Westmead Millennium Institute; Central Clinical School: MedicineTenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B, Gut (English Edition): an international journal of gastroenterology & hepatology, vol.60, 2,pp 247-254
2011Virological Response is Associated with Decline in Hemoglobin Concentration During Pegylated Interferon and Ribavirin Therapy in Hepatitis C Virus Genotype 1Weltman, Martin; Cheng, Wendy; Crawford, Darrell; DePamphilis, Jean; Dore, Gregory J.; McCaughan, Geoffrey; Rawlinson, William; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Yoshihara, Motoko; Nepean Clinical School: MedicineVirological Response is Associated with Decline in Hemoglobin Concentration During Pegylated Interferon and Ribavirin Therapy in Hepatitis C Virus Genotype 1, Hepatology, vol.53, 4, 2011,pp 1109-1117
2013Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infectionGeorge, Jacob; McCaughan, Geoffrey; Button, Peter; Cheng, Wendy; Crawford, Darrell H G; Dore, Gregory; Kitson, Matthew; Roberts, Stuart; Sievert, William; Weltman, Martin; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Centenary InstituteVitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection, Journal of Hepatology, vol.58, 3, 2013,pp 467-472